Shionogi & Co. Ltd.

18.11+0.00 (+0%)
Oct 28, 4:00:00 PM EDT · OTC Markets OTCPK · SGIOF · USD

Upcoming Earnings

Report date
-
Revenue
141.29B (123.05B ~ 158.40B)

Key Stats

Market Cap
17.54B
P/E (TTM)
10.41
Basic EPS (TTM)
1.74
Dividend Yield
0%

About

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

CEO
Dr. Isao Teshirogi Ph.D.
IPO
2/28/2018
Employees
4,955
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic